Sign in
Taking peopleNo phase

Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases and Immunosuppression

Key facts

Who runs it
Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Seps
Where
Germany10 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
300 people, planned
Started
28 Feb 2022
Expected to end
28 Feb 2028
Type of study
Observational
Record updated
13 March 2024

Who can take part

Age
18 years to 99 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Hospitalization with community acquired pneumonia (CAP) confirmed by pulmonary infiltrate in chest imaging
  • Valid informed consent form
  • Working diagnosis of CAP by enrolling physician
  • No hospitalization for any reason within 28 days prior to hospitalization for the current episode of CAP
  • At least 2 out of the five following clinical symptoms:; Fever; Cough; Purulent sputum; Shortness of breath or need for respiratory support; Crackling or rales on auscultation, dullness to percussion, or bronchial breathing
  • At least 1 of the following criteria; Known HIV infection or AIDS; Anti-tumor treatment within the past six months; Therapy with corticosteroids ≥ 20mg for ≥ 14 days before enrollment; Non-steroidal immunosuppressive therapy within the past six months; Cytostatic therapy within the past six months; Radiation therapy within the past six months; Bone marrow transplant received; Respiratory support at home via tracheostoma; Cystic fibrosis; Heart failure: New York Heart Association (NYHA) Stadium IV or HFrEF (defined as left ventricular ejection fraction <40%); Decompensated liver disease (Child-Pugh class C); Diabetes mellitus with HbA1c ≥ 8,5 %; End-stage renal disease requiring dialysis; Pulmonary hypertension (all classes) with mPAP > 20 mmHg (right heart catheter)

Who cannot take part

  • Active tuberculosis
  • Acute lung injury or acute respiratory distress syndrome for extrapulmonary reasons
  • Participation in this study at an earlier time
  • More than 48 hours in the hospital before enrollment (for patients directly to intensive care: more than 7 days)
  • Pregnancy
  • Breastfeeding
  • Massive aspiration
  • Sepsis with extrapulmonary focus
  • Acute pulmonary embolism

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 99 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Pneumonia is a common infectious disease of the lung, often requiring treatment in the hospital. Clinical scoring systems are available, identifying patients not requiring hospitalization. However, the course of disease of patients in the hospital remains hard to predict. While most patients will recover quickly, some will, despite appropriate treatment, develop a severe course leading to sepsis and systemic responses resulting in organ dysfunction. The PROGRESS consortium aims to identify clinical, genetic, and other molecular markers and combinations there of predicting a severe course of pneumonia in the hospital. Such predictors will, for instance, support decisions on earlier transfer of patients to intensive care and thus improving outcome. PROGRESS-COMORB aims to extend findings from the previous PROGRESS study to patients with more severe preexisting conditions and immunosuppression.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Study of Progression of Hospitalized Community Acquired Pneumonia - Genetic Resistance and Susceptibility for the Evolution of Severe Sepsis in Patients With More Severe Preexisting Diseases and Immunosuppression to Complement the PROGRESS CAP Cohort
Criteria questions
Built from NCT05688774, who can take part
Record updated
13 March 2024